| abstract |
Beta- and gamma-aminoisoquinolinamide compounds and substituted benzamide compounds are disclosed. Specifically, the present invention provides compounds that affect kinase function in cells and are useful as therapeutic agents or in combination with therapeutic agents. The compounds of the present invention are useful in the treatment of various diseases and conditions, such as eye diseases such as glaucoma, cardiovascular diseases, and diseases characterized by abnormal growth such as cancer. The present invention further provides a composition comprising a beta- or gamma-aminoisoquinolinamide compound or a substituted benzamide compound. |